PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayIn a large multicenter observational analysis evaluating electronic health records from international healthcare organizations, adults aged 50 years and older with low circulating serum zinc concentrations exhibited a significantly higher rate of newly recorded diagnoses of osteoporosis accompanied by pathological fracture compared to matched counterparts with normal zinc levels. The investigation, drawing on longitudinal patient records from the federated TriNetX Global Collaborative Network across 189 healthcare organizations, identified a 52 percent increase in the relative hazard of receiving an initial clinical diagnosis code for osteoporosis with current pathological fracture over up to six years of structured follow-up. While the finding establishes a statistically robust longitudinal association within a clinically tested cohort, the researchers emphasized that the absolute difference in recorded event rates remained modest, precluding any immediate inference that low zinc acts as an isolated, causal driver of skeletal deterioration rather than an overarching indicator of systemic frailty or physiological vulnerability.
Zinc operates as an essential trace mineral fundamentally integrated into skeletal biology, directly participating in osteoblast differentiation, collagen matrix synthesis, alkaline phosphatase activity, and continuous bone remodeling. At the cellular level, biological pathways such as the receptor activator of nuclear factor-kappa B ligand, receptor activator of nuclear factor-kappa B, and osteoprotegerin axis, known as the RANKL/RANK/OPG system, rely on balanced zinc availability to modulate osteoclastogenesis and prevent unrestrained bone resorption. Prior experimental models and early human supplementation trials in zinc-deficient individuals have demonstrated increases in bone mineral density markers and enhanced callus formation following traumatic fractures. However, translating these mechanistic observations into definitive longitudinal epidemiologic evidence has historically faced severe hurdles, as previous observational studies were predominantly cross-sectional, focused on single-sex cohorts, measured zinc levels after skeletal events had already occurred, or relied on bone mineral density measurements rather than clinically recorded fractures.
To overcome these historical methodological deficits, the research team designed a rigorous retrospective cohort study applying strict baseline landmark criteria to establish clear temporal ordering. Adults aged 50 years and older who had a verified serum or plasma zinc laboratory measurement documented between January 1, 2010, and December 31, 2023, were evaluated. Individuals with circulating zinc concentrations below 0.70 micrograms per milliliter were defined as the low-zinc cohort, whereas those maintaining concentrations within the standard physiological range of 0.70 to 1.20 micrograms per milliliter comprised the active control group. To prevent exposure misclassification, patients in the low-zinc cohort were excluded if they possessed any recorded zinc level of 0.70 micrograms per milliliter or higher during the preceding three-year lookback window, while controls were required to have no measured concentrations below 0.70 micrograms per milliliter or above 1.20 micrograms per milliliter across the same 1,095-day interval.
Cohort construction incorporated exhaustive pre-index exclusion criteria designed to remove individuals with pre-existing bone disorders or conditions that fundamentally alter mineral homeostasis. Patients were excluded if their baseline records showed prior diagnoses of osteoporosis with or without current pathological fracture, historical fractures across major skeletal sites including the proximal femur, thoracic or lumbar vertebrae, distal forearm, or proximal humerus, advanced chronic kidney disease, dialysis dependence, past bariatric surgery, or primary or metastatic bone malignancies. To avoid confounding induced by transient acute-phase reductions in circulating zinc, individuals who experienced acute kidney injury, sepsis, or critical care admissions within the 30 days immediately preceding the index laboratory test were removed. Furthermore, a 90-day post-index landmark window was applied, excluding any participant who died or experienced a qualifying skeletal outcome within days 1 to 90, thereby ensuring that prospective follow-up strictly encompassed day 91 through day 2,190.
Statistical balancing between the exposure cohorts was executed using rigorous one-to-one propensity score matching based on logistic regression models incorporating extensive demographic profiles, clinical comorbidities, nutritional indices, fracture-altering medications, and laboratory thresholds. The propensity algorithm accounted for conditions such as hypertension, diabetes mellitus, liver disease, chronic obstructive pulmonary disease, dementia, vitamin D deficiency, and malnutrition, alongside medications including benzodiazepines, proton pump inhibitors, systemic corticosteroids, insulin, and baseline zinc supplements. Threshold indicators for hemoglobin, estimated glomerular filtration rate, serum albumin, and glycated hemoglobin were matched across the groups. After greedy nearest-neighbor matching within a caliper of 0.1 pooled standard deviations of the logit score, 32,524 patients remained in each cohort, achieving absolute standardized mean differences below 0.10 across all matched baseline characteristics, with a mean cohort age of approximately 63.7 years and a female representation of roughly 55 percent.
Over the prospective monitoring window extending from day 91 through year six, a newly recorded diagnosis of osteoporosis with current pathological fracture, designated by the diagnostic code M80, occurred in 310 patients within the low-zinc cohort, representing an incidence of 0.95 percent. In contrast, the matched control cohort accumulated 217 events, representing an incidence of 0.67 percent. This corresponded to an absolute event-proportion difference of 0.29 percentage points and an estimated hazard ratio of 1.52, supported by a 95 percent confidence interval spanning 1.28 to 1.81 and a log-rank significance value below 0.001. Formal proportional-hazards testing yielded a p-value of 0.528, confirming that the hazard proportionality assumption held across the observation timeframe as Kaplan-Meier survival curves progressively diverged.
Prespecified exploratory skeletal endpoints aligned directionally with the primary finding, demonstrating elevated hazards across an array of anatomically categorized bone outcomes. An anatomically defined composite encompassing major osteoporotic-site fractures of the proximal femur, vertebrae, distal radius or ulna, and proximal humerus occurred in 1,262 low-zinc patients compared to 1,086 control patients, yielding a hazard ratio of 1.24 with a 95 percent confidence interval of 1.14 to 1.35. When evaluated individually, femoral fractures showed a hazard ratio of 1.34, while pelvic fractures demonstrated an elevated hazard ratio of 1.45. Furthermore, diagnoses of osteoporosis documented without a concurrent pathological fracture were more frequent among patients with low circulating zinc, generating a hazard ratio of 1.25. Concurrently, all-cause mortality was substantially higher among individuals with low baseline zinc, recording an event rate of 13.72 percent compared to 10.24 percent among controls, corresponding to a hazard ratio of 1.43.
To rigorously interrogate the vulnerability of these observational associations to unmeasured confounding and alternative clinical scenarios, the investigators conducted a series of sensitivity analyses, exposure stratifications, and control-outcome checks. In sensitivity models excluding patients with baseline malnutrition diagnoses, the hazard ratio for the primary fracture outcome remained consistent at 1.58, while restricting the cohort to index dates between 2017 and 2023 yielded an estimate of 1.47. In an exploratory analysis evaluating patients with severe zinc deficiency defined as concentrations at or below 0.50 micrograms per milliliter, the hazard ratio for newly recorded osteoporosis with pathological fracture rose to 2.16. Methodological integrity was further supported by control outcomes: pneumonia, selected as a positive control due to known links between zinc status and immune function, demonstrated an expected hazard ratio of 1.35, whereas acute appendicitis, evaluated as a negative control, showed no significant association with a hazard ratio of 0.93.
Exploratory subgroup analyses confirmed that the observed association between low circulating zinc and newly recorded pathological fractures was consistent across demographic and clinical strata. Stratified evaluations by sex, age categories divided at 65 years, presence of diabetes mellitus, baseline serum albumin above or below 3.5 grams per deciliter, obesity status, vitamin D deficiency, and underlying chronic kidney disease demonstrated no statistically significant between-stratum heterogeneity, with interaction p-values remaining above 0.20 across all strata. In parallel, sensitivity to unmeasured confounding was quantified using E-values, revealing that an unmeasured confounder would need an association with both zinc status and fracture risk corresponding to a risk ratio of at least 2.41 for the point estimate, and 1.88 for the lower confidence bound, to fully attenuate the observed findings to the null.
Despite the consistency of these statistical associations, the authors emphasized critical limitations inherent in real-world electronic health record databases that necessitate cautious interpretation. Diagnostic billing codes cannot differentiate low-energy fragility fractures from high-energy traumatic injuries, nor can they rule out instances where a newly entered diagnosis represents subsequent clinical management or sequelae of a pre-existing fracture. Furthermore, serum zinc is an imperfect physiological biomarker that drops during systemic inflammation and cannot capture total-body zinc reserves. Because routine clinical practice does not involve universal zinc screening, individuals undergoing testing represent a selected patient population characterized by underlying medical indications. Combined with higher all-cause mortality and shorter median follow-up in the low-zinc cohort, low circulating zinc may primarily mark comprehensive systemic illness, undernutrition, or frailty. The researchers concluded that while these findings generate vital hypotheses regarding nutritional status and skeletal resilience, prospective longitudinal trials with repeated biomarker tracking and randomized clinical trials are required before considering zinc testing or supplementation for fracture prevention.
Subject of Research: Epidemiological association between low serum zinc and newly recorded osteoporosis with pathological fracture in older adults
Article Title: Association between low serum zinc concentration and newly recorded osteoporosis with pathological fracture among adults aged 50 years and older
Article References: Chang, Y.-J., Wang, W.-T., Pang, Y.-L., Liao, S.-W., & Lan, K.-M. (2026). Association between low serum zinc concentration and newly recorded osteoporosis with pathological fracture among adults aged 50 years and older. Frontiers in Nutrition, 13, Article 2026242. https://doi.org/10.3389/fnut.2026.2026242
Image Credits: AI Generated
DOI: 10.3389/fnut.2026.2026242
Keywords: serum zinc, zinc deficiency, osteoporosis, pathological fracture, bone health, bone remodeling, retrospective cohort, TriNetX network, propensity score matching, femoral fracture, pelvic fracture, all-cause mortality, nutritional epidemiology, geriatric health, electronic health records, competing risks


40 minutes ago
9




















English (US) ·
French (CA) ·